MISSISSIPPI LEGISLATURE

2010 2nd Extraordinary Session

To: Judiciary A

By: Representatives Blackmon, Huddleston (15th), Palazzo, Bondurant, Upshaw, Reed, Nowell, Patterson, Jones (111th), Chism, Morgan, Martinson, Pigott

House Bill 1

(As Passed the House)

AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, TO INCLUDE VARIOUS SYNTHETIC CANNABINOIDS IN SCHEDULE I; AND FOR RELATED PURPOSES.

     WHEREAS, the Mississippi Legislature finds that there is a growing use of the unregulated synthetic cannabinoids commonly known as K2 or synthetic marijuana; and

     WHEREAS, preliminary studies indicate that the three synthetic cannabinoid substances unregulated in Mississippi are from three to over 100 times more potent than THC, the active ingredient found in marijuana; and

     WHEREAS, many states as well as the federal government have already included one or more of these chemical compounds on Schedules of Controlled Substances, but none of these chemicals are currently listed on Mississippi's Schedule of Controlled Substances; and

     WHEREAS, synthetic cannabinoids are referred to as the new marijuana, and K2 is gaining in popularity at an alarming rate among high school and college students and persons on probation and parole; and

     WHEREAS, while having the same or stronger physiological effects as high potency marijuana, synthetic marijuana or K2 does not show a positive reading in a urinalysis test which adds to the desirability and increased growth among drug abusers and increases the threat to public health and safety by avoiding detection; and

     WHEREAS, the Mississippi Legislature should address the growing threat of synthetic cannabinoids to the health, safety and welfare of our citizens before the problem becomes epidemic in the State of Mississippi.

     BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI:

     SECTION 1.  Section 41-29-113, Mississippi Code of 1972, is amended as follows:

     41-29-113.  The controlled substances listed in this section are included in Schedule I.

SCHEDULE I

     (a)  Opiates.  Any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:

          (1)  Acetyl-alpha-methylfentanyl;

          (2)  Acetylmethadol;

          (3)  Allylprodine;

          (4)  Alphacetylmethadol, except levo-alphacetylmethadol (levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM);

          (5)  Alphameprodine;

          (6)  Alphamethadol;

          (7)  Alpha-methylfentanyl;

          (8)  Alpha-methylthiofentanyl;

          (9)  Benzethidine;

          (10)  Betacetylmethadol;

          (11)  Beta-hydroxyfentanyl;

          (12)  Beta-hydroxy-3-methylfentanyl;

          (13)  Betameprodine;

          (14)  Betamethadol;

          (15)  Betaprodine;

          (16)  Clonitazene;

          (17)  Dextromoramide;

          (18)  Diampromide;

          (19)  Diethylthiambutene;

          (20)  Difenoxin;

          (21)  Dimenoxadol;

          (22)  Dimepheptanol;

          (23)  Dimethylthiambutene;

          (24)  Dioxaphetyl butyrate;

          (25)  Dipipanone;

          (26)  Ethylmethylthiambutene;

          (27)  Etonitazene;

          (28)  Etoxeridine;

          (29)  Furethidine;

          (30)  Hydroxypethidine;

          (31)  Ketobemidone;

          (32)  Levomoramide;

          (33)  Levophenacylmorphan;

          (34)  3-methylfentanyl;

          (35)  3-methylthiofentanyl;

          (36)  Morpheridine;

          (37)  MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

          (38)  Noracymethadol;

          (39)  Norlevorphanol;

          (40)  Normethadone;

          (41)  Norpipanone;

          (42)  Para-fluorofentanyl;

          (43)  PEPAP (1-(-2-phenylethyl)-4-phenyl-4-acetoxypiperidine);

          (44)  Phenadoxone;

          (45)  Phenampromide;

          (46)  Phenomorphan;

          (47)  Phenoperidine;

          (48)  Piritramide;

          (49)  Proheptazine;

          (50)  Properidine;

          (51)  Propiram;

          (52)  Racemoramide;

          (53)  Thiofentanyl;

          (54)  Tilidine;

          (55)  Trimeperidine.

     (b)  Opiate derivatives.  Any of the following opium derivatives, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

          (1)  Acetorphine;

          (2)  Acetyldihydrocodeine;

          (3)  Benzylmorphine;

          (4)  Codeine methylbromide;

          (5)  Codeine-N-Oxide;

          (6)  Cyprenorphine;

          (7)  Desomorphine;

          (8)  Dihydromorphine;

          (9)  Drotebanol;

          (10)  Etorphine; (except hydrochloride salt);

          (11)  Heroin;

          (12)  Hydromorphinol;

          (13)  Methyldesorphine;

          (14)  Methyldihydromorphine;

          (15)  Monoacetylmorphine;

          (16)  Morphine methylbromide;

          (17)  Morphine methylsulfonate;

          (18)  Morphine-N-Oxide;

          (19)  Myrophine;

          (20)  Nicocodeine;

          (21)  Nicomorphine;

          (22)  Normorphine;

          (23)  Pholcodine;

          (24)  Thebacon.

     (c)  Hallucinogenic substances.  Any material, compound, mixture or preparation which contains any quantity of the following * * * substances, their salts, * * * isomers (whether optical, positional, or geometric) and salts of isomers, unless specifically excepted, whenever the existence of these salts, * * * isomers and salts of isomers is possible within the specific chemical designation:

          (1)  3,4-methylenedioxy amphetamine;

          (2)  5-methoxy-3,4-methylenedioxy amphetamine;

          (3)  2,5-dimethoxy-4-ethylamphetamine (DOET);

          (4)  2,5-dimethoxy-4(n) propylthiophenethylamine (2C-T-7);

          (5)  3,4-methylenedioxymethamphetamine (MDMA);

          (6)  3,4,5-trimethoxy amphetamine;

          (7)  Alpha-methyltryptamine (Also known as AMT);

          (8)  Bufotenine;

          (9)  Diethyltryptamine;

          (10)  Dimethyltryptamine;

          (11)  5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT);

          (12)  Alpha-ethyltryptamine;

          (13)  4-methyl-2,5-dimethoxyamphetamine;

          (14)  Hashish;

          (15)  Ibogaine;

          (16)  Lysergic acid diethylamide (LSD);

          (17)  Marihuana;

          (18)  Mescaline;

          (19)  Peyote;

          (20)  N-ethyl-3-piperidyl benzilate;

          (21)  N-methyl-3-piperidyl benzilate;

          (22)  Phencyclidine;

          (23)  Psilocybin;

          (24)  Psilocyn;

          (25)  Tetrahydrocannabinols, meaning tetrahydrocannabinols contained in a plant of the genus Cannabis (cannabis plant), as well as the synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant such as the following:

               (A)  -1 cis or trans tetrahydrocannabinol * * *;

               (B)  -6 cis or trans tetrahydrocannabinol * * *;

               (C)  -3,4 cis or trans tetrahydrocannabinol * * *.

     (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of atomic positions are covered.)       ("Tetrahydrocannabinols" excludes dronabinol and nabilone.)

     However, the following products are exempted from control:  THC-containing industrial products (e.g., (i) paper, rope and clothing made from cannabis stalks; (ii) processed cannabis plant materials used for industrial purposes, such as fiber retted from cannabis stalks for use in manufacturing textiles or rope; (iii) animal feed mixtures that contain sterilized cannabis seeds and other ingredients (not derived from the cannabis plant) in a formula designed, marketed and distributed for nonhuman consumption; and (iv) personal care products that contain oil from sterilized cannabis seeds, such as shampoos, soaps, and body lotions (provided that such products do not cause THC to enter the human body);

          (26)  2,5-dimethoxyamphetamine;

          (27)  4-bromo-2,5-dimethoxyamphetamine;

          (28)  4-bromo-2,5-dimethoxyphenylethylamine;

          (29)  4-methoxyamphetamine;

          (30)  Ethylamine analog of phencyclidine (PCE);

          (31)  Pyrrolidine analog of phencyclidine (PHP, PCPy);

          (32)  Thiophene analog of phencyclidine;

          (33)  Parahexyl;

          (34)  1-[1-(2-thienyl)cyclohexyl] pyrrolidine (TCPy);

          (35)  3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenylethylamine, N-ethyl MDA, MDE, MDEA);

          (36)  N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy MDA, N-OHMDA, and N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenylethylamine);

          (37)  Salvia divinorum;

          (38)  Synthetic cannabinoids:

               (A)  1-pentyl-3-(1-naphthoyl)indole (also known as JWH-018);

               (B)  (6aR,10aR)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (also known as HU-210 or 1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol);

               (C)  2-(3-hydroxycyclohexyl)-5-(2-methyloctan-2-yl)

phenol(also known as CP-47,497), and the dimethylhexyl, dimethyloctyl and dimethylnonyl homologues of CP-47,497;

               (D)  1-butyl-3-(1-naphthoyl)indole (also known as JWH-073);

               (E)  1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl) indole (also known as JWH-200);

               (F)  1-pentyl-3-(2-methoxyphenylacetyl)indole (also known as JWH-250);

               (G)  1-hexyl-3-(1-naphthoyl)indole (also known as JWH-019);

               (H)  1-pentyl-3-(4-chloro-1-naphthoyl)indole (also known as JWH-398).

     (d)  Depressants.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

          (1)  Gamma-hydroxybutyric acid (other names include:  GHB, gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);

          (2)  Mecloqualone;

          (3)  Methaqualone.

     (e)  Stimulants.  Any material, compound, mixture or preparation which contains any quantity of the following central nervous system stimulants including optical salts, isomers and salts of isomers unless specifically excepted or unless listed in another schedule:

          (1)  Aminorex;

          (2)  N-benzylpiperazine (also known as BZP; 1-benzylpiperazine);

          (3)  Cathinone;

          (4)  Fenethylline;

          (5)  N-ethyl-amphetamine;

          (6)  4-methylaminorex (also known as 2-amino-4-methyl-5-phenyl-2-oxazoline);

          (7)  Methcathinone;

          (8)  Any material, compound, mixture or preparation which contains any quantity of N,N-dimethylamphetamine.  (Other names include:  N,N,-alpha-trimethyl-benzeneethanamine, and N,N-alphatrimethylphenethylamine).

     SECTION 2.  This act shall take effect and be in force from and after its passage.